Anticancer Effects of Niclosamide in Human Glioblastoma | Clinical Cancer Research

44–46)nHighlight:It is a salicylanilide that was introduced as a molluscide in 1959nHighlight:Studies in animals suggested no mutagenic, oncogenic, or embryotoxic activity and no cumulative effectsnHighlight:its rate of absorption from the intestinal tract was estimated at only 33%nHighlight:the potential mechanism of synergy between temozolomide and niclosamide as a “natural inducer” of NFKBIAn]]>

About Dr. Nathan Goodyear
About Dr. Nathan Goodyear

Dr. Nathan Goodyear, a medical doctor with years of experience in the field of integrative cancer care, has announced the launch of an online training program. This program, available on his new website, will provide individuals with access to video trainings led by Dr. Goodyear himself, covering a range of topics related to integrative cancer care. These trainings will include information on the latest research and techniques in the field, as well as guidance on how to incorporate these approaches into a patient’s overall cancer treatment plan. With this online program, Dr. Goodyear hopes to make his expertise and knowledge more widely accessible, and help more people understand the benefits of integrative cancer care.

READ MORE

Leave a Comment

Your email address will not be published. Required fields are marked *

Skip to content